|
1
|
Yagui-Beltrán A and Jablons DM: A
translational approach to lung cancer research. Ann Thorac
Cardiovasc Surg. 15:2132009.PubMed/NCBI
|
|
2
|
Okudela K, Nagahara N, Katayama A and
Kitamura H: Cancer Stem Cells in Lung Cancer: Distinct Differences
between Small Cell and Non-Small Cell Lung Carcinomas. Cancer Stem
Cells Theories and Practice. InTech. 2011 https://www.intechopen.com/.../cancer-stem-cells-theorieMarch
22–2011. View
Article : Google Scholar
|
|
3
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Caramori G, Casolari P, Cavallesco GN,
Giuffrè S, Adcock I and Papi A: Mechanisms involved in lung cancer
development in COPD. Int J Biochem Cell Biol. 43:1030–1044. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Buttery RC, Rintoul RC and Sethi T: Small
cell lung cancer: The importance of the extracellular matrix. Int J
Biochem Cell Biol. 36:1154–1160. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pei J, Lou Y, Zhong R and Han B: MMP9
activation triggered by epidermal growth factor induced FoxO1
nuclear exclusion in non-small cell lung cancer. Tumour Biol.
35:6673–6678. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang J, Li ZH, White J and Zhang LB: Lung
cancer stem cells and implications for future therapeutics. Cell
Biochem Biophys. 69:389–398. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vermeulen L, Sprick MR, Kemper K, Stassi G
and Medema JP: Cancer stem cells - old concepts, new insights. Cell
Death Differ. 15:947–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Freitas DP, Teixeira CA, Santos-Silva F,
Vasconcelos MH and Almeida GM: Therapy-induced enrichment of
putative lung cancer stem-like cells. Int J Cancer. 134:1270–1278.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dingli D and Michor F: Successful therapy
must eradicate cancer stem cells. Stem Cells. 24:2603–2610. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen X, Liao R, Li D and Sun J: Induced
cancer stem cells generated by radiochemotherapy and their
therapeutic implications. Oncotarget. 8:17301–17312.
2017.PubMed/NCBI
|
|
12
|
Tang Q-L, Liang Y, Xie XB, Yin JQ, Zou CY,
Zhao ZQ, Shen JN and Wang J: Enrichment of osteosarcoma stem cells
by chemotherapy. Chin J Cancer. 30:426–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liloglou T, Bediaga NG, Brown BR, Field JK
and Davies MP: Epigenetic biomarkers in lung cancer. Cancer Lett.
342:200–212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Allan AL, Vantyghem SA, Tuck AB and
Chambers AF: Tumor dormancy and cancer stem cells: Implications for
the biology and treatment of breast cancer metastasis. Breast Dis.
26:87–98. 2006-2007. View Article : Google Scholar
|
|
15
|
Lobo NA, Shimono Y, Qian D and Clarke MF:
The biology of cancer stem cells. Annu Rev Cell Dev Biol.
23:675–699. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Velasco-Velázquez MA, Popov VM, Lisanti MP
and Pestell RG: The role of breast cancer stem cells in metastasis
and therapeutic implications. Am J Pathol. 179:2–11. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Maitland NJ and Collins AT: Prostate
cancer stem cells: A new target for therapy. J Clin Oncol.
26:2862–2870. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kozovska Z, Gabrisova V and Kucerova L:
Colon cancer: Cancer stem cells markers, drug resistance and
treatment. Biomed Pharmacother. 68:911–916. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Prince ME, Sivanandan R, Kaczorowski A,
Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF and Ailles
LE: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang JC and Dick JE: Cancer stem cells:
Lessons from leukemia. Trends Cell Biol. 15:494–501. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kristiansen G, Schlüns K, Yongwei Y,
Denkert C, Dietel M and Petersen I: CD24 is an independent
prognostic marker of survival in nonsmall cell lung cancer
patients. Br J Cancer. 88:231–236. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tirino V, Camerlingo R, Franco R, Malanga
D, La Rocca A, Viglietto G, Rocco G and Pirozzi G: The role of
CD133 in the identification and characterisation of
tumour-initiating cells in non-small-cell lung cancer. Eur J
Cardiothorac Surg. 36:446–453. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Leung EL-H, Fiscus RR, Tung JW, Tin VP,
Cheng LC, Sihoe AD, Fink LM, Ma Y and Wong MP: Non-small cell lung
cancer cells expressing CD44 are enriched for stem cell-like
properties. PLoS One. 5:e140622010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang WC, Shyh-Chang N, Yang H, Rai A,
Umashankar S, Ma S, Soh BS, Sun LL, Tai BC, Nga ME, et al: Glycine
decarboxylase activity drives non-small cell lung cancer
tumor-initiating cells and tumorigenesis. Cell. 148:259–272. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin S, Sun JG, Wu JB, Long HX, Zhu CH,
Xiang T, Ma H, Zhao ZQ, Yao Q, Zhang AM, et al: Aberrant microRNAs
expression in CD133+/CD326+ human lung
adenocarcinoma initiating cells from A549. Mol Cells. 33:277–283.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Laimer K, Fong D, Gastl G, Obrist P, Kloss
F, Tuli T, Gassner R, Rasse M, Norer B and Spizzo G: EpCAM
expression in squamous cell carcinoma of the oral cavity: Frequency
and relationship to clinicopathologic features. Oral Oncol.
44:72–77. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Litvinov SV, van Driel W, van Rhijn CM,
Bakker HA, van Krieken H, Fleuren GJ and Warnaar SO: Expression of
Ep-CAM in cervical squamous epithelia correlates with an increased
proliferation and the disappearance of markers for terminal
differentiation. Am J Pathol. 148:865–875. 1996.PubMed/NCBI
|
|
29
|
Munz M, Baeuerle PA and Gires O: The
emerging role of EpCAM in cancer and stem cell signaling. Cancer
Res. 69:5627–5629. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pak MG, Shin DH, Lee CH and Lee MK:
Significance of EpCAM and TROP2 expression in non-small cell lung
cancer. World J Surg Oncol. 10:53–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Skirecki T, Hoser G, Kawiak J, Dziedzic D
and Domagała-Kulawik J: Flow cytometric analysis of
CD133− and EpCAM-positive cells in the peripheral blood
of patients with lung cancer. Arch Immunol Ther Exp (Warsz).
62:67–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tachezy M, Zander H, Wolters-Eisfeld G,
Müller J, Wicklein D, Gebauer F, Izbicki JR and Bockhorn M:
Activated leukocyte cell adhesion molecule (CD166): An ‘inert’
cancer stem cell marker for non-small cell lung cancer? Stem Cells.
32:1429–1436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
de Beça FF, Caetano P, Gerhard R,
Alvarenga CA, Gomes M, Paredes J and Schmitt F: Cancer stem cells
markers CD44, CD24 and ALDH1 in breast cancer special histological
types. J Clin Pathol. 66:187–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jing F, Kim HJ, Kim CH, Kim YJ, Lee JH and
Kim HR: Colon cancer stem cell markers CD44 and CD133 in patients
with colorectal cancer and synchronous hepatic metastases. Int J
Oncol. 46:1582–1588. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Takaishi S, Okumura T, Tu S, Wang SS,
Shibata W, Vigneshwaran R, Gordon SA, Shimada Y and Wang TC:
Identification of gastric cancer stem cells using the cell surface
marker CD44. Stem Cells. 27:1006–1020. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Su J, Wu S, Wu H, Li L and Guo T: CD44 is
functionally crucial for driving lung cancer stem cells metastasis
through Wnt/β-catenin-FoxM1-Twist signaling. Mol Carcinog.
55:1962–1973. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Barrandon Y and Green H: Cell size as a
determinant of the clone-forming ability of human keratinocytes.
Proc Natl Acad Sci USA. 82:5390–5394. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zakaria N, Yusoff NM, Zakaria Z, Lim MN,
Baharuddin PJ, Fakiruddin KS and Yahaya B: Human non-small cell
lung cancer expresses putative cancer stem cell markers and
exhibits the transcriptomic profile of multipotent cells. BMC
Cancer. 15:842015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shi Y, Fu X, Hua Y, Han Y, Lu Y and Wang
J: The side population in human lung cancer cell line NCI-H460 is
enriched in stem-like cancer cells. PLoS One. 7:e333582012.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang P, Gao Q, Suo Z, Munthe E, Solberg S,
Ma L, Wang M, Westerdaal NA, Kvalheim G and Gaudernack G:
Identification and characterization of cells with cancer stem cell
properties in human primary lung cancer cell lines. PLoS One.
8:e570202013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Levin TG, Powell AE, Davies PS, Silk AD,
Dismuke AD, Anderson EC, Swain JR and Wong MH: Characterization of
the intestinal cancer stem cell marker CD166 in the human and mouse
gastrointestinal tract. Gastroenterology. 139:2072–2082.e5. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li W, Ma H, Zhang J, Zhu L, Wang C and
Yang Y: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem
cell markers in tumorigenesis and metastasis. Sci Rep. 7:138562017.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bahnassy AA, Fawzy M, El-Wakil M, Zekri
AR, Abdel-Sayed A and Sheta M: Aberrant expression of cancer stem
cell markers (CD44, CD90, and CD133) contributes to disease
progression and reduced survival in hepatoblastoma patients: 4-year
survival data. Transl Res. 165:396–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang H, Lin XG, Hua P, Wang M, Ao X,
Xiong LH, Wu C and Guo JJ: The study of the tumor stem cell
properties of CD133+ CD44+ cells in the human
lung adenocarcinoma cell line A549. Cell Mol Biol (Noisy-le-grand).
56 Suppl:OL1350–8. 2010.PubMed/NCBI
|
|
45
|
Barrandon Y and Green H: Three clonal
types of keratinocyte with different capacities for multiplication.
Proc Natl Acad Sci USA. 84:2302–2306. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yan W, Chen Y, Yao Y, Zhang H and Wang T:
Increased invasion and tumorigenicity capacity of
CD44+/CD24− breast cancer MCF7 cells in vitro
and in nude mice. Cancer Cell Int. 13:622013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dean M, Fojo T and Bates S: Tumour stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Huang C-P, Tsai MF, Chang TH, Tang WC,
Chen SY, Lai HH, Lin TY, Yang JC, Yang PC, Shih JY, et al:
ALDH-positive lung cancer stem cells confer resistance to epidermal
growth factor receptor tyrosine kinase inhibitors. Cancer Lett.
328:144–151. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Izumiya M, Kabashima A, Higuchi H,
Igarashi T, Sakai G, Iizuka H, Nakamura S, Adachi M, Hamamoto Y,
Funakoshi S, et al: Chemoresistance is associated with cancer stem
cell-like properties and epithelial-to-mesenchymal transition in
pancreatic cancer cells. Anticancer Res. 32:3847–3853.
2012.PubMed/NCBI
|
|
51
|
Todaro M, Alea MP, Di Stefano AB,
Cammareri P, Vermeulen L, Iovino F, Tripodo C, Russo A, Gulotta G,
Medema JP, et al: Colon cancer stem cells dictate tumor growth and
resist cell death by production of interleukin-4. Cell Stem Cell.
1:389–402. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Chen Y-C, Chen YW, Hsu HS, Tseng LM, Huang
PI, Lu KH, Chen DT, Tai LK, Yung MC, Chang SC, et al: Aldehyde
dehydrogenase 1 is a putative marker for cancer stem cells in head
and neck squamous cancer. Biochem Biophys Res Commun. 385:307–313.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Huang EH, Hynes MJ, Zhang T, Ginestier C,
Dontu G, Appelman H, Fields JZ, Wicha MS and Boman BM: Aldehyde
dehydrogenase 1 is a marker for normal and malignant human colonic
stem cells (SC) and tracks SC overpopulation during colon
tumorigenesis. Cancer Res. 69:3382–3389. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Charafe-Jauffret E, Ginestier C, Iovino F,
Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci
F, Jacquemier J, et al: Aldehyde dehydrogenase 1-positive cancer
stem cells mediate metastasis and poor clinical outcome in
inflammatory breast cancer. Clin Cancer Res. 16:45–55. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak
J, Xing L, Wang H, Liu Z, Su Y, Stass SA, et al: Aldehyde
dehydrogenase 1 is a tumor stem cell-associated marker in lung
cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Tanei T, Morimoto K, Shimazu K, Kim SJ,
Tanji Y, Taguchi T, Tamaki Y and Noguchi S: Association of breast
cancer stem cells identified by aldehyde dehydrogenase 1 expression
with resistance to sequential Paclitaxel and epirubicin-based
chemotherapy for breast cancers. Clin Cancer Res. 15:4234–4241.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Bouchier-Hayes L, Muñoz-Pinedo C, Connell
S and Green DR: Measuring apoptosis at the single cell level.
Methods. 44:222–228. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ma D, Tremblay P, Mahngar K, Akbari-Asl P,
Collins J, Hudlicky T and Pandey S: Induction of apoptosis and
autophagy in human pancreatic cancer cells by a novel synthetic C-1
analogue of 7-deoxypancratistatin. Am J Biomed Sci. 3:278–291.
2011. View Article : Google Scholar
|
|
59
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Wang X, Zhu Y, Ma Y, Wang J, Zhang F, Xia
Q and Fu D: The role of cancer stem cells in cancer metastasis: New
perspective and progress. Cancer Epidemiol. 37:60–63. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang F, Ma L, Zhang Z, Liu X, Gao H,
Zhuang Y, Yang P, Kornmann M, Tian X and Yang Y: Hedgehog signaling
regulates epithelial-mesenchymal transition in pancreatic cancer
stem-like cells. J Cancer. 7:408–417. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Singh A and Settleman J: EMT, cancer stem
cells and drug resistance: An emerging axis of evil in the war on
cancer. Oncogene. 29:4741–4751. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ni J, Cozzi P, Hao J, Beretov J, Chang L,
Duan W, Shigdar S, Delprado W, Graham P, Bucci J, et al: Epithelial
cell adhesion molecule (EpCAM) is associated with prostate cancer
metastasis and chemo/radioresistance via the PI3K/Akt/mTOR
signaling pathway. Int J Biochem Cell Biol. 45:2736–2748. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Patriarca C, Macchi RM, Marschner AK and
Mellstedt H: Epithelial cell adhesion molecule expression (CD326)
in cancer: A short review. Cancer Treat Rev. 38:68–75. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Wielenga VJ, Smits R, Korinek V, Smit L,
Kielman M, Fodde R, Clevers H and Pals ST: Expression of CD44 in
Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J
Pathol. 154:515–523. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Hou J-M, Krebs M, Ward T, Sloane R, Priest
L, Hughes A, Clack G, Ranson M, Blackhall F and Dive C: Circulating
tumor cells as a window on metastasis biology in lung cancer. Am J
Pathol. 178:989–996. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Mizrak SC, Chikhovskaya JV, Sadri-Ardekani
H, van Daalen S, Korver CM, Hovingh SE, Roepers-Gajadien HL, Raya
A, Fluiter K, de Reijke TM, et al: Embryonic stem cell-like cells
derived from adult human testis. Hum Reprod. 25:158–167. 2010.
View Article : Google Scholar : PubMed/NCBI
|
